Get Real Time Here
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biogen Stock (NASDAQ:BIIB), Quotes and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open258.440 | Close257.520 |
| Vol / Avg.806.443K / 1.004M | Mkt Cap37.295B |
| Day Range255.160 - 261.375 | 52 Wk Range194.690 - 334.580 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 4.000 | (EXPECTED) 2023-10-24 | |||||
| REV | 2.390B | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.770 | 4.020 | 0.2500 | ||||
| REV | 2.370B | 2.456B | 86.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 360.00 |
| 2023-09-05 | Morgan Stanley | Matthew Harrison | Maintains | OverweightOverweight | Raises | 363.00 | 381.00 |
| 2023-08-29 | RBC Capital | Brian Abrahams | Maintains | OutperformOutperform | Raises | 354.00 | 357.00 |
| 2023-08-14 | Mizuho | Salim Syed | Maintains | BuyBuy | Lowers | 340.00 | 335.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIIB | Biogen | -0.21% | 37.3B |
| LEGN | Legend Biotech | 5.66% | 12.4B |
| EXAS | Exact Sciences | 1.55% | 12.2B |
| SRPT | Sarepta Therapeutics | 3.37% | 11.5B |
| NBIX | Neurocrine Biosciences | 0.7% | 11.3B |
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
Who are Biogen's (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Biogen (BIIB) stock?
The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.
Current Stock Price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.
Does Biogen (BIIB) pay a dividend?
There is no dividend information for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.